TCL Archive Swedish Study Finds Long Term Hormonal Therapy May Increase Breast Cancer Risk August 4, 1989
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment September 23, 2011
TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992
